A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologiesErnest Turro, Willem H. Ouwehand, Claire Lentaigne et al.|Science Translational Medicine|2016Cited by 144
High-Dose Intravenous Immunoglobulin Treatment of a Pregnant Patient with an Antiphospholipid Syndrome: Immunological Changes Associated with a Successful OutcomeJozef Arnout, Jos Vermylen, Bernard Spitz et al.|Thrombosis and Haemostasis|1994Cited by 54